Browsing Tag
Schroders Capital
2 posts
Taiho Pharmaceutical to expand ADC portfolio with Araris Biotech acquisition
Taiho Pharmaceutical is acquiring Araris Biotech for $1.14 billion, strengthening its ADC oncology pipeline. Discover how this deal is shaping the future of cancer treatment.
March 24, 2025
Schroders Capital invests in Neurona Therapeutics to advance neural cell therapies
In a significant development for the life sciences sector, Schroders Capital Global Innovation Trust plc has announced a…
February 9, 2024